{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T19:27:41Z","timestamp":1790105261623,"version":"4.0.1"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,3]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>The effect of maternal HIV on infant <jats:italic toggle=\"yes\">Mycobacterium tuberculosis<\/jats:italic> (Mtb) infection risk is not well-characterized.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>Pregnant women with\/without HIV and their infants were enrolled in a longitudinal cohort in Kenya. Mothers had interferon gamma-release assays (QFT-Plus) and tuberculin skin tests (TST) at enrollment in pregnancy; children underwent TST at 12 and 24 months of age. We estimated the incidence and correlates of infant TST-positivity using Cox proportional hazards regression.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Among 322 infants, 170 (53%) were HIV-exposed and 152 (47%) were HIV-unexposed. Median enrollment age was 6.6 weeks [interquartile range (IQR): 6.1\u201310.0]; most received Bacillus Calmette-Guerin (320, 99%). Thirty-nine (12%) mothers were TST-positive; 102 (32%) were QFT-Plus-positive. Among HIV-exposed infants, 154 (95%) received antiretrovirals for HIV prevention and 141 (83%) of their mothers ever received isoniazid preventive therapy (IPT). Cumulative 24-month infant Mtb infection incidence was 3.6\/100 person-years (PY) [95% confidence interval (CI): 2.4\u20135.5\/100 PY]; 5.4\/100 PY in HIV-exposed infants (10%, 17\/170) versus 1.7\/100 PY in HIV-unexposed infants (3.3%, 5\/152) [hazard ratio (HR): 3.1 (95% CI: 1.2\u20138.5)]. More TST conversions occurred in the first versus second year of life [5.8 vs. 2.0\/100 PY; HR: 2.9 (95% CI: 1.0\u201310.1)]. Infant TST-positivity was associated with maternal TST-positivity [HR: 2.9 (95% CI: 1.1\u20137.4)], but not QFT-Plus-positivity. Among HIV-exposed children, Mtb infection incidence was similar regardless of maternal IPT.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions:<\/jats:title>\n            <jats:p>Mtb infection incidence (by TST) by 24 months of age was ~3-fold higher among HIV-exposed children, despite high maternal IPT uptake. Overall, more TST conversions occurred in the first 12 months compared to 12\u201324 months of age, similar in both HIV-exposed and HIV-unexposed children.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/inf.0000000000004190","type":"journal-article","created":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T14:48:57Z","timestamp":1700664537000},"page":"250-256","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Maternal HIV Status and Risk of Infant Mycobacterium tuberculosis Infection as Measured by Tuberculin Skin Test"],"prefix":"10.1097","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-6446-0395","authenticated-orcid":false,"given":"Jerphason","family":"Mecha","sequence":"first","affiliation":[{"name":"Centre for Respiratory Diseases Research, Kenya Medical Research Institute, Nairobi, Kenya"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3513-774X","authenticated-orcid":false,"given":"Jaclyn N.","family":"Escudero","sequence":"additional","affiliation":[{"name":"Department of Global Health, University of Washington, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbra A.","family":"Richardson","sequence":"additional","affiliation":[{"name":"Department of Global Health, University of Washington, Seattle, Washington"},{"name":"Department of Biostatistics, University of Washington, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Maleche-Obimbo","sequence":"additional","affiliation":[{"name":"Department of Global Health, University of Washington, Seattle, Washington"},{"name":"Department of Paediatrics and Child Health, University of Nairobi, Nairobi, Kenya"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Matemo","sequence":"additional","affiliation":[{"name":"Research and Programs, Kenyatta National Hospital, Nairobi, Kenya"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Kinuthia","sequence":"additional","affiliation":[{"name":"Department of Global Health, University of Washington, Seattle, Washington"},{"name":"Research and Programs, Kenyatta National Hospital, Nairobi, Kenya"},{"name":"Department of Reproductive Health, Kenyatta National Hospital, Nairobi, Kenya"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"John-Stewart","sequence":"additional","affiliation":[{"name":"Department of Global Health, University of Washington, Seattle, Washington"},{"name":"Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington"},{"name":"Department of Epidemiology, University of Washington, Seattle, Washington"},{"name":"Department of Pediatrics, University of Washington, Seattle, Washington."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9809-5997","authenticated-orcid":false,"given":"Sylvia M.","family":"LaCourse","sequence":"additional","affiliation":[{"name":"Department of Global Health, University of Washington, Seattle, Washington"},{"name":"Division of Allergy and Infectious Diseases, Department of Medicine, University of Washington, Seattle, Washington"},{"name":"Department of Epidemiology, University of Washington, Seattle, Washington"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,11,22]]},"reference":[{"key":"R1-20250614","doi-asserted-by":"crossref","first-page":"e453","DOI":"10.1016\/S2214-109X(14)70245-1","article-title":"Burden of childhood tuberculosis in 22 high-burden countries: a mathematical modelling study.","volume":"2","author":"Dodd","year":"2014","journal-title":"Lancet Glob Health"},{"key":"R2-20250614","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S0140-6736(20)30166-5","article-title":"The risk of tuberculosis in children after close exposure: a systematic review and individual-participant meta-analysis.","volume":"395","author":"Martinez","year":"2020","journal-title":"Lancet"},{"key":"R3-20250614","first-page":"225","article-title":"Tuberculosis exposure in HIV-exposed infants in a high-prevalence setting.","volume":"12","author":"Cotton","year":"2008","journal-title":"Int J Tuberc Lung Dis"},{"key":"R4-20250614","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1097\/INF.0000000000000124","article-title":"High prevalence of tuberculosis infection in HIV-1 exposed Kenyan infants.","volume":"33","author":"Cranmer","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"R5-20250614","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.5588\/ijtld.15.0602","article-title":"Source Case Identification in HIV-exposed infants and Tuberculosis diagnosis in an Isoniazid prevention study.","volume":"20","author":"Maritz","year":"2016","journal-title":"Int J Tuberc Lung Dis"},{"key":"R6-20250614","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1086\/649887","article-title":"Mortality among HIV-exposed infants: the first and final frontier.","volume":"50","author":"Shapiro","year":"2010","journal-title":"Clin Infect Dis"},{"key":"R7-20250614","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1097\/QAD.0000000000000292","article-title":"In-utero exposure to maternal HIV infection alters T-cell immune responses to vaccination in HIV-uninfected infants.","volume":"28","author":"Kidzeru","year":"2014","journal-title":"AIDS"},{"key":"R8-20250614","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/QAD.0000000000000536","article-title":"The impact of HIV exposure and maternal Mycobacterium tuberculosis infection on infant immune responses to bacille Calmette-Gu\u00e9rin vaccination.","volume":"29","author":"Jones","year":"2015","journal-title":"AIDS"},{"key":"R9-20250614","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1097\/INF.0000000000001062","article-title":"Tuberculosis infection in early childhood and the association with HIV-exposure in HIV-uninfected children in Rural Uganda.","volume":"35","author":"Marquez","year":"2016","journal-title":"Pediatr Infect Dis J"},{"key":"R10-20250614","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1056\/NEJMoa1011214","article-title":"Primary isoniazid prophylaxis against tuberculosis in HIV-exposed children.","volume":"365","author":"Madhi","year":"2011","journal-title":"N Engl J Med"},{"key":"R12-20250614","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1086\/506432","article-title":"Tuberculin skin testing in patients with HIV infection: limited benefit of reduced cutoff values.","volume":"43","author":"Cobelens","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R13-20250614","first-page":"758","article-title":"Tuberculin skin test reactions by time of reading among Dutch travellers.","volume":"7","author":"Cobelens","year":"2003","journal-title":"Int J Tuberc Lung Dis"},{"key":"R14-20250614","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/QAI.0000000000002827","article-title":"Interferon gamma release assay and tuberculin skin test performance in pregnant women living with and without HIV.","volume":"89","author":"Kaplan","year":"2022","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R16-20250614","doi-asserted-by":"crossref","first-page":"e96613","DOI":"10.1371\/journal.pone.0096613","article-title":"Tuberculin skin test reversion following isoniazid preventive therapy reflects diversity of immune response to primary Mycobacterium tuberculosis infection.","volume":"9","author":"Johnson","year":"2014","journal-title":"PLoS One"},{"key":"R17-20250614","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1093\/cid\/ciac393","article-title":"Cumulative Mycobacterium tuberculosis infection incidence (measured primarily by tuberculin skin test) among infants with human immunodeficiency virus exposure: observational follow-up of an isoniazid prophylaxis trial.","volume":"75","author":"LaCourse","year":"2022","journal-title":"Clin Infect Dis"},{"key":"R18-20250614","doi-asserted-by":"crossref","first-page":"e034308","DOI":"10.1136\/bmjopen-2019-034308","article-title":"Infant TB Infection Prevention Study (iTIPS): a randomised trial protocol evaluating isoniazid to prevent M. tuberculosis infection in HIV-exposed uninfected children.","volume":"10","author":"LaCourse","year":"2020","journal-title":"BMJ Open"},{"key":"R19-20250614","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S2352-4642(17)30149-9","article-title":"Tuberculin skin test conversion and primary progressive tuberculosis disease in the first 5 years of life: a birth cohort study from Cape Town, South Africa.","volume":"2","author":"Martinez","year":"2018","journal-title":"Lancet Child Adolesc Health"},{"key":"R20-20250614","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/INF.0b013e3181ecbf7e","article-title":"Morbidity among human immunodeficiency virus-exposed but uninfected, human immunodeficiency virus-infected, and human immunodeficiency virus-unexposed infants in Zimbabwe before availability of highly active antiretroviral therapy.","volume":"30","author":"Koyanagi","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"R21-20250614","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1097\/INF.0b013e31825b9524","article-title":"Hearing Loss in Perinatally HIV-infected and HIV-exposed but Uninfected Children and Adolescents.","volume":"31","author":"Torre","year":"2012","journal-title":"Pediatr Infect Dis J"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000004190","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,15]],"date-time":"2025-06-15T00:03:24Z","timestamp":1749945804000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000004190"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,22]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000004190","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11,22]]}}}